Mesa Laboratories (MLAB) Total Non-Current Liabilities (2012 - 2026)
Mesa Laboratories' (MLAB) quarterly Total Non-Current Liabilities came in at $227.8 million in Q1 2026, down 12.72% year-over-year from $261.0 million in Q1 2025, and down 3.94% quarter-over-quarter from $237.2 million in Q4 2025.
Analysis
Mesa Laboratories (MLAB) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
Mesa Laboratories has disclosed Total Non-Current Liabilities across 15 years of filings, most recently posting $227.8 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 12.72% year-over-year to $227.8 million; the TTM figure through Mar 2026 stood at $227.8 million (down 12.72% YoY), while the FY2026 annual figure was $227.8 million, down 12.72% from the prior year.
- Total Non-Current Liabilities came in at $227.8 million for Q1 2026 at Mesa Laboratories, down from $237.2 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $321.5 million in Q4 2023 to a low of $227.8 million in Q1 2026.
- Average Total Non-Current Liabilities over 5 years is $267.5 million, with a median of $262.2 million recorded in 2023.
- Year-over-year, Total Non-Current Liabilities surged 57.12% in 2022 and retreated 18.8% in 2024.
- Over 5 years, Total Non-Current Liabilities stood at $267.6 million in 2022, then rose by 20.13% to $321.5 million in 2023, then decreased by 18.8% to $261.0 million in 2024, then slipped by 9.14% to $237.2 million in 2025, then decreased by 3.94% to $227.8 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $227.8 million in Q1 2026, $237.2 million in Q4 2025, and $240.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 55.95 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 33.25 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 6.06 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | 3.52 Bn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 4.05 Bn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 457.16 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 2.88 Bn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | 821.06 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | 197.96 Mn |
| 10 | Mesa Laboratories | 684.72 Mn | 652.49 Mn | 39.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 227.84 Mn |
| Dec 31, 2025 | 237.20 Mn |
| Sep 30, 2025 | 240.12 Mn |
| Jun 30, 2025 | 250.59 Mn |
| Mar 31, 2025 | 261.05 Mn |
| Dec 31, 2024 | 261.05 Mn |
| Sep 30, 2024 | 277.99 Mn |
| Jun 30, 2024 | 283.05 Mn |
| Mar 31, 2024 | 285.79 Mn |
| Dec 31, 2023 | 321.49 Mn |
| Sep 30, 2023 | 243.99 Mn |
| Jun 30, 2023 | 248.14 Mn |
| Mar 31, 2023 | 262.20 Mn |
| Dec 31, 2022 | 267.61 Mn |
| Sep 30, 2022 | 275.17 Mn |
| Jun 30, 2022 | 298.04 Mn |
| Mar 31, 2022 | 305.64 Mn |
| Dec 31, 2021 | 317.05 Mn |
| Sep 30, 2021 | 209.25 Mn |
| Jun 30, 2021 | 212.96 Mn |